• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (125)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

II. Relationship to Catecholamines, REM Sleep, and Drugs

William E. Bunney, Jr., MD; Frederick K. Goodwin, MD; Dennis L. Murphy, MD; Kenneth M. House, MD; Edna K. Gordon

Arch Gen Psychiatry. 1972;27(3):304-309.

Abstract

The data reported in this paper support the hypothesis that the neurotransmitter catecholamines (dopamine and/or norepinephrine) are functionally increased prior to the switch from depression into mania. Urinary norepinephrine was significantly elevated on the day prior to and during the manic episodes. Overall sleep and rapid eye movement were both decreased prior to and during the switch into mania in a few patients. Our pharmacological data is also supportive of this hypothesis. Brief administration of tricyclic medication has been associated with rapid switches from depression into mania. Large doses of levodopa (which increases brain dopamine) were regularly associated with brief hypomanic episodes in patients with past histories of mania. On the other hand, methyl-tyrosine, which inhibits the synthesis of norepinephrine and dopamine, was associated with a transitory switch out of mania in a few patients.

Author Affiliations

From the Section on Psychiatry (Drs. Bunney, Goodwin, Murphy, and House) and the Unit on Clinical Biochemistry, Office of the Chief (E. Gordon), Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md.

Footnotes

Reprint requests to Section on Psychiatry, Laboratory of Clinical Science, NIMH, 9000 Rockville Pike, Bethesda, Md 20014 (Dr. Bunney).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association Between Bipolar Spectrum Features and Treatment Outcomes in Outpatients With Major Depressive Disorder
Perlis et al.
Arch Gen Psychiatry 2011;68:351-360.
ABSTRACT | FULL TEXT  

Empirical typology of bipolar I mood episodes
Solomon et al.
Br. J. Psychiatry 2009;195:525-530.
ABSTRACT | FULL TEXT  

Rapid Switching of Mood in Families With Multiple Cases of Bipolar Disorder
MacKinnon et al.
Arch Gen Psychiatry 2003;60:921-928.
ABSTRACT | FULL TEXT  

Switching From 'Unipolar' to Bipolar II: An 11-Year Prospective Study of Clinical and Temperamental Predictors in 559 Patients
Akiskal et al.
Arch Gen Psychiatry 1995;52:114-123.
ABSTRACT  

Effects of Antidepressant Treatments on Dopamine Turnover in Depressed Patients
Linnoila et al.
Arch Gen Psychiatry 1983;40:1015-1017.
ABSTRACT  

Thyroid Abnormalities Associated With Rapid-Cycling Bipolar Illness
Cowdry et al.
Arch Gen Psychiatry 1983;40:414-420.
ABSTRACT  

Selective and Nonselective Monoamine Oxidase Inhibitors: Behavioral Disturbances During Their Administration to Depressed Patients
Pickar et al.
Arch Gen Psychiatry 1982;39:535-540.
ABSTRACT  

Clomipramine-Induced Mania in Unipolar Depression
van Scheyen and van Kammen
Arch Gen Psychiatry 1979;36:560-565.
ABSTRACT  

Toward a Biochemical Classification of Depressive Disorders: I. Differences in Urinary Excretion of MHPG and Other Catecholamine Metabolites in Clinically Defined Subtypes of Depressions
Schildkraut et al.
Arch Gen Psychiatry 1978;35:1427-1433.
ABSTRACT  

The Switch Process in Manic-Depressive Psychosis
BUNNEY et al.
ANN INTERN MED 1977;87:319-335.
ABSTRACT  

MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep
Schildkraut et al.
Science 1973;181:762-764.
ABSTRACT  

Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles
Jones et al.
Science 1973;179:300-302.
ABSTRACT